Vascular Therapies Stock

Vascular Therapies is a biopharma company that aims to improve vascular surgery outcomes in patients with kidney and vascular diseases.

Sign up today and learn more about Vascular Therapies Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Vascular Therapies Stock

Vascular Therapies (VT) is a biopharmaceutical company committed to the development and commercialization of innovative new treatments to address major unmet clinical needs of patients requiring a vascular access to support hemodialysis. Our lead product candidate, containing sirolimus, has received orphan drug designations in the U.S. and E.U. for the dialysis vascular access indications. The company was founded in 2001 and headquartered in Cresskill, New Jersey.

Funding History

April 2011$646K
June 2011$3.2M
July 2013$5.2M
February 2015$16.2M
October 2018$12.4M
November 2019$7.4M
January 2020$17.3M
August 2021$3.7M
March 2022$24.0M


Founder, Chief Scientific Officer & Board Member

Sriram Iyer


John McDermott


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: